Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Polymerase chain reaction (PCR) detects rhesus in transcervical samples:

This article was originally published in Clinica

Executive Summary

Researchers from the UK MRC say foetal rhesus factor can be ascertained by PCR amplification of transcervical samples. In a letter to The Lancet (February 4th), Dr M Adinolfi says both aspiration of cervical mucus at 10 weeks and lavage between 6 and 13 weeks harvested sufficient foetal trophoblasts to determine rhesus status in ten out of 12 women tested. The researchers say these preliminary results indicate at least 2.5 cellular elements are probably required for reliable analysis. A larger trial is now under way at University College London.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts